Add BrightSurf on Google Email

New support for a serotonin deficit in depression

Researchers found reduced serotonin release capacity in individuals with depression, suggesting a blunted serotonin system. The study used novel imaging techniques to measure serotonin levels in the brain, providing crucial insights into the pathology of depression.

SourceElsevier·JournalBiological Psychiatry·TypeExperimental study·DateDec 15, 2022

Making mosquitoes’ love songs fall on deaf ears

Researchers at Nagoya University have developed a new method to control mosquito populations by altering the frequency of sound that males listen for. By using serotonin-inhibiting compounds, they reduced the range of frequencies males respond to and their response itself.

SourceNagoya University·JournalFrontiers in Physiology·TypeExperimental study·DateNov 14, 2022

New insights into how serotonin regulates behavior

New research by Frank Schroeder's team reveals two parallel biosynthetic pathways for serotonin production in C. elegans, challenging the long-held assumption that serotonin is made and quickly broken down. The findings suggest new therapeutic targets for treating anxiety, depression, and eating disorders.

SourceBoyce Thompson Institute·JournalNature Chemical Biology·TypeExperimental study·DateOct 13, 2022

Tracking down satiety mechanisms in the stomach

Researchers at Leibniz-Institut für Lebensmittel-Systembiologie an der TU München discovered that casein digestion produces peptides with a satiating effect, stimulating gastric acid secretion via bitter receptors. This mechanism may help regulate food intake and maintain a healthy body weight.

SourceLeibniz-Institut für Lebensmittel-Systembiologie an der TU München·JournalJournal of Agricultural and Food Chemistry·TypeExperimental study·DateOct 11, 2022

How the gut may help to drive COVID-19

New research from Flinders University found a molecular link between COVID-19 and serotonin cells in the gut. The study suggests that these cells synthesise and release serotonin, which is highly enriched for SARS-CoV-2 receptors, potentially worsening disease outcomes.

SourceFlinders University·JournalGut·TypeObservational study·DateAug 31, 2022

Making sense of socially enhanced aggression in the brain

Scientists from the University of Tsukuba discovered that the lateral habenula brain region plays a crucial role in amplifying aggressive behavior in response to social interactions. Blocking this pathway eliminated increased aggression caused by social instigation, highlighting its significance in promoting aggressive arousal.

SourceUniversity of Tsukuba·JournalNature Communications·DateJul 22, 2022

New study in Journal of Pharmaceutical Analysis marries modern science with traditional knowledge to decipher anti-diarrheal effect of cashew stem bark extract

A new study found that cashew stem bark extract inhibits abnormal gut motility associated with diarrhea, revealing a potential low-cost remedy for treating and managing the condition. The extract's mechanism of action involves blocking muscarinic acetylcholine receptors responsible for gastrointestinal motility.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateFeb 23, 2022

COVID patients on SSRI antidepressants are less likely to die, UCSF-Stanford study finds

A large US-based analysis of electronic health records found that people taking SSRI antidepressants, particularly fluoxetine, were significantly less likely to die from COVID-19. The results add to evidence suggesting SSRIs may have beneficial effects against the worst symptoms of COVID-19.

SourceUniversity of California - San Francisco·JournalJAMA Network Open·TypeComputational simulation/modeling·DateNov 15, 2021

Hopkins Med newsletter 7

Researchers identified a pattern that links the accumulation of amyloid beta (Aβ) proteins with a reduction of serotonin, which may help predict who will develop late-life depression. The study found that individuals expressing this pattern had more severe depressive symptoms.

SourceJohns Hopkins Medicine·JournalTranslational Psychiatry·DateOct 7, 2021

Antidepressants inhibit cancer growth in mice

Researchers found that antidepressants inhibit the growth of pancreatic and colon cancers in mice by blocking a mechanism used by cancer cells to evade the immune system. The findings suggest a promising approach for combining antidepressant drugs with immunotherapy to treat incurable cancers.

SourceUniversity of Zurich·JournalScience Translational Medicine·DateSep 28, 2021

Gut microbes: a key to normal sleep

A study published in Scientific Reports found that mice without gut microbes had altered sleep patterns, including increased REM and non-REM sleep episodes. The researchers discovered that gut microbes play a crucial role in producing neurotransmitters like serotonin, which regulate sleep-wake cycles.

SourceUniversity of Tsukuba·JournalScientific Reports·DateNov 30, 2020

Happiness and the evolution of brain size

Researchers found that serotonin can stimulate the production of basal progenitor cells in the fetal human brain, potentially contributing to the evolutionary expansion of the neocortex. This new function of serotonin may help explain the development of neurodevelopmental and psychiatric disorders.

SourceMax-Planck-Gesellschaft·JournalNeuron·DateOct 23, 2020

Scientists report role for dopamine and serotonin in human perception and decision-making

Researchers recorded real-time changes in dopamine and serotonin levels in patients' brains during tasks, revealing that serotonin levels increased with uncertainty and decreased with confidence. The study provides insight into how dopamine and serotonin regulate perception, decision-making, and cognition, potentially leading to improv...

Guilt by dissociation: Study sheds light on serotonin in autism

Researchers at Florida Atlantic University have made significant progress in understanding the role of serotonin in autism. The study found that a specific mutation in the serotonin transporter protein can lead to altered serotonin levels and behavior changes, shedding light on the underlying mechanisms of autism. Further work is neede...

SourceFlorida Atlantic University·JournalFrontiers in Molecular Neuroscience·DateSep 2, 2020

Modified Parkinson's drug shows potential in treating nonalcoholic fatty liver disease

Scientists from GIST developed a novel peripheral serotonin antagonist, which showed promising results in obese mice with impaired liver function. The compound improved symptoms of fatty liver disease and reduced body fat. Researchers hope the drug candidate will offer relief to patients with nonalcoholic fatty liver disease.

SourceGIST (Gwangju Institute of Science and Technology)·JournalJournal of Medicinal Chemistry·DateMay 28, 2020

New drug can ease the side effects of medication against severe depression

Researchers at the University of Copenhagen have discovered a substance, Lu AF60097, that can regulate serotonin levels in the brain and reduce severe side effects associated with tricyclic antidepressants. This new approach may allow for more effective treatment of severe depression while minimizing potential harm.

Human medicines affect fish behavior

Research reveals that human medicines influencing serotonin and dopamine systems alter the boldness and explorative behaviour of three-spined sticklebacks, highlighting potential consequences for aquatic ecosystems. The study confirms the role of these signal substances in individual personality differences and stress resilience.

SourceLinköping University·JournalJournal of Experimental Biology·DateOct 16, 2019